Motif ID: TBP
Z-value: 3.641
Transcription factors associated with TBP:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
TBP | ENSG00000112592.8 | TBP |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
1.3 | 3.9 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.1 | 4.6 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.1 | 5.7 | GO:0015827 | tryptophan transport(GO:0015827) leucine import(GO:0060356) |
1.1 | 4.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.0 | 3.1 | GO:0009635 | response to herbicide(GO:0009635) |
0.6 | 5.7 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.5 | 2.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.8 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.5 | 16.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 1.3 | GO:0060279 | progesterone secretion(GO:0042701) regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.4 | 1.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 4.4 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.4 | 2.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 2.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 10.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 2.0 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 1.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 2.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 0.9 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 1.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 10.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 1.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 1.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.5 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.7 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 3.6 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.5 | GO:0032849 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 0.4 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 0.5 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 4.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 2.8 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 1.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 1.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0032845 | negative regulation of homeostatic process(GO:0032845) |
0.1 | 1.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 2.9 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 17.9 | GO:0008544 | epidermis development(GO:0008544) |
0.1 | 0.2 | GO:0045852 | regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.7 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 7.3 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.1 | 0.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.1 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.5 | GO:0034465 | cellular potassium ion homeostasis(GO:0030007) response to carbon monoxide(GO:0034465) negative regulation of cell volume(GO:0045794) smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 2.0 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 1.9 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 1.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 1.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0007620 | insemination(GO:0007320) copulation(GO:0007620) |
0.0 | 0.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 4.2 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 2.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 2.3 | GO:0030336 | negative regulation of cell migration(GO:0030336) negative regulation of cell motility(GO:2000146) |
0.0 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 1.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 1.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.3 | GO:0043588 | skin development(GO:0043588) |
0.0 | 1.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 5.9 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 16.2 | GO:0007010 | cytoskeleton organization(GO:0007010) |
0.0 | 1.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 1.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 3.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.7 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 3.0 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.0 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.2 | GO:0019627 | urea metabolic process(GO:0019627) |
0.0 | 0.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.3 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
0.0 | 0.3 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.7 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.2 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.5 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 6.2 | GO:0006935 | chemotaxis(GO:0006935) taxis(GO:0042330) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.7 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.2 | GO:0042269 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 28.1 | GO:0045095 | keratin filament(GO:0045095) |
0.7 | 19.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 1.3 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.4 | 3.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 18.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.3 | 2.8 | GO:0031430 | M band(GO:0031430) |
0.3 | 1.1 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.2 | 0.7 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.2 | 4.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 2.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 3.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 4.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 7.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 1.5 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 2.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 2.3 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 2.6 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 3.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 1.1 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0016592 | mediator complex(GO:0016592) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 22.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.1 | 4.6 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 5.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 10.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 1.9 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.5 | 7.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 3.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.3 | GO:0048184 | obsolete follistatin binding(GO:0048184) |
0.4 | 1.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 2.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 0.7 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.3 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 30.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 2.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 10.5 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 2.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 2.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 1.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 2.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 2.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 2.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 5.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 7.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 11.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 2.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 1.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.0 | 0.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) ubiquitin binding(GO:0043130) |
0.0 | 2.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 2.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 1.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 17.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.9 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 1.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 4.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.6 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.3 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 1.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 7.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 7.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.4 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.7 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.2 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
0.0 | 0.3 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |